| Simvastatin | Approved Investigational | CDT1 | 81620 |
downregulated | Simvastatin results in decreased expression of CDT1 mRNA | 16q24.3 | |
| Simvastatin | Approved Investigational | COL1A1 | 1277 |
downregulated | Simvastatin results in decreased expression of COL1A1 mRNA | 17q21.33 | |
| Simvastatin | Approved Investigational | COL1A1 | 1277 |
upregulated | Simvastatin results in increased expression of COL1A1 mRNA | 17q21.33 | |
| Simvastatin | Approved Investigational | COL3A1 | 1281 |
upregulated | Simvastatin results in increased expression of COL3A1 mRNA | 2q32.2 | |
| Simvastatin | Approved Investigational | COL7A1 | 1294 |
upregulated | Simvastatin results in increased expression of COL7A1 mRNA | 3p21.31 | |
| Simvastatin | Approved Investigational | CTLA4 | 1493 |
downregulated | Simvastatin results in decreased expression of CTLA4 mRNA | 2q33.2 | |
| Simvastatin | Approved Investigational | CTNNAL1 | 8727 |
downregulated | Simvastatin results in decreased expression of CTNNAL1 mRNA | 9q31.3 | |
| Simvastatin | Approved Investigational | CX3CR1 | 1524 |
downregulated | Simvastatin results in decreased expression of CX3CR1 mRNA | 3p22.2 | |
| Simvastatin | Approved Investigational | CXCL8 | 3576 |
downregulated | Simvastatin results in decreased expression of CXCL8 mRNA | 4q13.3 | |
| Simvastatin | Approved Investigational | CYP2B6 | 1555 |
upregulated | Simvastatin results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Simvastatin | Approved Investigational | CYP3A4 | 1576 |
upregulated | [Simvastatin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Simvastatin | Approved Investigational | CYP3A4 | 1576 |
upregulated | Simvastatin results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Simvastatin | Approved Investigational | CYR61 | 3491 |
downregulated | Simvastatin results in decreased expression of CYR61 mRNA | 1p22.3 | |
| Simvastatin | Approved Investigational | DBF4 | 10926 |
downregulated | Simvastatin results in decreased expression of DBF4 mRNA | 7q21.12 | |
| Simvastatin | Approved Investigational | DSPP | 1834 |
upregulated | Simvastatin results in increased expression of DSPP mRNA | 4q22.1 | |
| Simvastatin | Approved Investigational | E2F1 | 1869 |
downregulated | Simvastatin results in decreased expression of E2F1 mRNA | 20q11.22 | |
| Simvastatin | Approved Investigational | EDN1 | 1906 |
downregulated | Simvastatin results in decreased expression of EDN1 mRNA | 6p24.1 | |
| Simvastatin | Approved Investigational | F3 | 2152 |
downregulated | Simvastatin results in decreased expression of F3 mRNA | 1p21.3 | |
| Simvastatin | Approved Investigational | F3 | 2152 |
upregulated | Simvastatin results in increased expression of F3 mRNA | 1p21.3 | |
| Simvastatin | Approved Investigational | FASN | 2194 |
upregulated | Simvastatin results in increased expression of FASN mRNA | 17q25.3 | |
| Simvastatin | Approved Investigational | FDFT1 | 2222 |
upregulated | Simvastatin results in increased expression of FDFT1 mRNA | 8p23.1 | |
| Simvastatin | Approved Investigational | FDPS | 2224 |
upregulated | Simvastatin results in increased expression of FDPS mRNA | 1q22 | |
| Simvastatin | Approved Investigational | FOS | 2353 |
downregulated | Simvastatin results in decreased expression of FOS mRNA | 14q24.3 | |
| Simvastatin | Approved Investigational | GJB2 | 2706 |
upregulated | Simvastatin results in increased expression of GJB2 mRNA | 13q12.11 | |
| Simvastatin | Approved Investigational | HMGCR | 3156 |
upregulated | Simvastatin results in increased expression of HMGCR mRNA | 5q13.3 | |